Islamic jurisprudence generally permits the use of life-saving medical treatments derived from animal sources—including porcine components—when no viable, pure alternative is available under the principle of necessity (Darurah). However, modern biotechnology has largely shifted production away from animal pancreases toward recombinant DNA technology, allowing manufacturers to produce synthetic human insulin using yeast or bacteria, which avoids animal products entirely.